It is associated with type II cobblestone lissencephaly, hydrocephalus, cerebellar malformations, eye abnormalities and congenital muscular dystrophy characterized by hypoglycosylation of α-dystroglycan. The gene discussed is DAG1; the disease is congenital muscular dystrophy due to LMNA mutation.